Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 3:4:17.
doi: 10.3389/fonc.2014.00017. eCollection 2014.

Nilotinib for the Frontline Treatment of Chronic Myeloid Leukemia Carrying the p230 Transcript: Dream or Reality?

Maurizio Capuozzo  1 , Alessandro Ottaiano  2 , Eduardo Nava  1 , Stefania Cascone  1 , Claudia Cinque  3 , Adriano Vercellone  1 , Corinne Scognamiglio  1 , Emilia Palumbo  1 , Rosario V Iaffaioli  2
Affiliations
Review

Nilotinib for the Frontline Treatment of Chronic Myeloid Leukemia Carrying the p230 Transcript: Dream or Reality?

Maurizio Capuozzo et al. Front Oncol. .
No abstract available

Keywords: chromosomal translocation; chronic myeloid leukemia; e19a2 rearrangement; nilotinib; tyrosine kinase inhibitors.

PubMed Disclaimer

References

    1. O’Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med (2003) 348:994–100410.1056/NEJMoa022457 - DOI - PubMed
    1. Parker WT, Yeoman AL, Jamison BA, Yeung DT, Scott HS, Hughes TP, et al. BCR-ABL1 kinase domain mutations may persist at very low levels for many years and lead to subsequent TKI resistance. Br J Cancer (2013) 109:1593–810.1038/bjc.2013.318 - DOI - PMC - PubMed
    1. Janas JA, Van Aelst L. Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation. Mol Cell Biol (2011) 31:2552–6510.1128/MCB.05045-11 - DOI - PMC - PubMed
    1. Ohsaka A, Hoshino S, Kobayashi M, Kudo H, Kawaguchi R. Blast crisis of Philadelphia chromosome-positive chronic myeloid leukaemia carrying micro-bcr breakpoint (e19a2 and e191a). Br J Haematol (2002) 118:251–410.1046/j.1365-2141.2002.03570.x - DOI - PubMed
    1. Greco M, Caocci G, La Nasa G. Early complete molecular response to first-line nilotinib in two patients with chronic myeloid leukemia carrying the p230 transcript. Case Rep Hematol (2013) 2013:871476.10.1155/2013/871476 - DOI - PMC - PubMed

LinkOut - more resources